3D-Printed Organs Market By Organ (Heart, Liver, Kidney, Lung, Skin, Bone), Technology (Extrusion-Based 3D Printing, Laser-Assisted Printing, Inkjet Printing, Magnetic Levitation), Material, Application, End-user & Region - Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits - Forecast 2024-2032

Industry : Healthcare | Pages : 180 Pages | Published On : Mar 2024

         
     
The 3D-Printed Organs Market is Valued USD 2.99 billion by 2030 and projected to reach , growing at a CAGR of 18.51% During the Forecast period of 2024-2032.

3D-Printed Organs Market Size


Graph
             2020                         2024-2032      

ReportDetails
Market Size ValueUSD 2.99 billion by 2030
CAGR18.51%
Forecast Period2024-2032
Base Year 2023
Historic Data2020

Major Players In 3D-Printed Organs Market Include: Organovo Holdings Inc., Modern Meadow, Poietis, REGEMAT 3D S.L., Cellbricks, Nano3D Biosciences, Inc., Medprin Regenerative Medical Technologies Co., Ltd, EnvisionTEC, nScrypt, Advanced Solutions, Inc., Digilab Inc., TeVido BioDevices, Aspect Biosystems Ltd., Cyfuse Biomedical K.K., CELLINK GLOBAL, 3D Systems, BioBots, Rokit Healthcare, Tissue Regenix Group, LIFE 3D and Others.

Market Overview

The market for 3D-printed organs signifies a groundbreaking progression at the convergence of biotechnology, medical science, and additive manufacturing. This domain revolves around harnessing 3D printing technology to fabricate fully operational human organs, employing a method that constructs layer upon layer while adhering to the principles of regenerative medicine. The substantial growth of the 3D-printed organs market is substantially attributed to the widespread occurrence of chronic illnesses. Moreover, heightened utilization and deployment of 3D organs, coupled with an aging demographic more inclined toward medical procedures, bolster the overall market expansion. The mounting research and development endeavors in 3D printing technology, coupled with governmental investments in pertinent projects, are poised to unveil novel prospects for market advancement. However, the creation of 3D-printed organs can entail considerable costs due to the specialized apparatus, materials, and expertise involved. Ensuring the compatibility of bio-inks and materials to avoid immune responses remains a pivotal challenge. The 3D-printed organs arena holds substantial potential to reshape the medical panorama by mitigating organ shortages and redefining transplantation methodologies. Although challenges persist, the continuous strides in technology, materials, and research are projected to impel the market onward, thereby paving the path for an era where customized, functional organs materialize as reality.

Growing demand for organ transplants and the shortage of available organs for transplantation

The market's expansion is fueled by an increasing demand for organ transplants and the inadequacy of available organs for transplantation. Traditional transplantation relies on organs donated by deceased or living individuals, yet a substantial disparity exists between the number of patients requiring transplants and the accessible organs. This deficit leads to protracted waiting lists and frequently culminates in patient fatalities prior to suitable organs becoming accessible. The advent of 3D-printed organs holds promise in remedying this shortage by enabling the fabrication of organs as needed, tailored to individual patient requirements. This innovation has the potential to fundamentally transform the transplantation field by offering a solution to the scarcity of organs. Through 3D printing, organs can be produced to precisely match the patient's anatomical structure, thereby reducing the risk of organ rejection and bolstering transplant success rates. The rapid production facilitated by 3D printing shortens the time patients spend on transplant waiting lists, consequently enhancing their odds of survival. These bioprinted organs are an integral component of the wider regenerative medicine domain, which strives to repair or substitute damaged tissues and organs, thereby revolutionizing medical practices across diverse fields. Nevertheless, it is noteworthy that the development and widespread acceptance of 3D-printed organs encounter challenges such as regulatory clearance, scalability, cost-effectiveness, and long-term safety. While the potential advantages are substantial, further efforts are imperative to fully actualize the potential of this technology within the healthcare sector.

Market Dynamics

Drivers:

  • Increasing geriatric population with chronic respiratory diseases
  • Advances in 3D printing technology
  • Development of new bioinks

Opportunities:

  • Improvement of 3D printing techniques
  • Advancements in Biomaterials

Improvement of 3D printing techniques

The evolution of 3D printing techniques has been nothing short of remarkable, marked by a continuous quest for improvement and innovation. One significant area of enhancement lies in precision and resolution. Advancements in printing technologies, such as stereolithography and selective laser sintering, have allowed for finer details and smoother surfaces in printed objects. This increased precision is particularly crucial in the field of 3D-printed organs, where intricate anatomical structures demand a high level of accuracy. Moreover, improvements in printing speed have been a focal point. Faster printing not only enhances efficiency but also broadens the scope of applications, making 3D printing more viable for large-scale production in various industries. This acceleration is attributed to developments in both hardware and software, streamlining the entire printing process. Furthermore, the shift toward multi-material and multi-modal printing has opened new possibilities. Combining different materials in a single print allows for the creation of complex, heterogeneous structures with diverse properties. In the context of 3D-printed organs, this capability is instrumental in replicating the intricate composition of natural tissues and organs. The continuous improvement of 3D printing techniques is a dynamic and interdisciplinary endeavor. It involves advancements in hardware, software, materials, and intelligent systems, all converging to push the boundaries of what is possible in the realm of additive manufacturing. As these techniques advance, the potential for groundbreaking applications, particularly in the field of 3D-printed organs, continues to expand, bringing us closer to a future where personalized, functional organs are a reality.

The market for 3D-printed organs is dominated by North America.

In 2023, North America takes the lead in the 3D-printed organs market, trailed by Europe and Asia-Pacific. The North American region is characterized by a heightened incidence of chronic ailments like heart disease, cancer, and diabetes. These conditions often culminate in organ failure, significantly propelling the demand for 3D-printed organs. Substantial investments from both governmental bodies and private organizations in North America are channeled into the research and development of 3D-printed organs. Consequently, this momentum fuels the emergence of novel and advanced 3D printing technologies, facilitating the creation of intricate and lifelike organs. In the realm of North American 3D-printed organs, prominent players such as Organovo Holdings, Inc., RegenHU, Inc., and 3D Bioprinting Solutions, Inc., hold sway. These entities commit substantial resources to research and development endeavors, propelling innovation and ushering innovative products into the market.

Asia-Pacific is poised to undergo swift expansion within the 3D-printed organs market. Demonstrating an exceptional propensity for embracing novel technologies, the region is adept at rapidly assimilating innovations. This predisposition positions the area favorably to harness advancements in 3D printing, particularly in the realm of organ fabrication. The region's densely populated and diverse demographic provides an extensive reservoir of potential patients for organ transplants. This substantial recipient pool fosters a heightened demand for forward-looking solutions like 3D-printed organs. Furthermore, numerous countries in Asia-Pacific have made remarkable advancements in medical research and healthcare innovation. The synergy of medical expertise with cutting-edge 3D printing technology is expected to expedite both the development and adoption of 3D-printed organs. In light of these factors, it is anticipated that Asia-Pacific will observe a notable upswing in research, developmental initiatives, and the incorporation of 3D-printed organs in the years to come. This trajectory is poised to significantly contribute to the accelerated expansion of the market across the region.

The Transplantation Segment is Anticipated to Hold the Largest Market Share During the Forecast Period

Based on application, the market is segmented into Transplantation, Research & Drug Testing, Disease Modeling, Regenerative Medicine and Medical Training & Education. The Transplantation segment is anticipated to take the lead in the 3D-printed organs market in the coming years. This is mainly attributed to the substantial gap in demand and supply for organ transplants on a global scale. The scarcity of organs has resulted in extended waiting lists and unfavorable outcomes for patients. The emergence of 3D-printed organs holds the promise of addressing this shortage and delivering life-saving treatments to a considerable number of patients.

Segmentations Analysis of 3D-Printed Organs Market: -

Major Segmentations Are Distributed as follows:

  • By Organ Type
    • Heart
    • Liver
    • Kidney
    • Lung
    • Skin
    • Bone
    • Pancreas
    • Ear
    • Eye
    • Others
  • By Technology Type
    • Extrusion-Based 3D Printing
    • Laser-Assisted Printing
    • Inkjet Printing
    • Stereolithography
    • Magnetic Levitation
    • Laser Based
    • Others
  • By Material Type
    • Biological Materials (Bioinks)
    • Synthetic Polymers
    • Hydrogels
    • Ceramics
    • Metals
    • Biomaterials
  • By Application
    • Transplantation
    • Research & Drug Testing
    • Disease Modeling
    • Regenerative Medicine
    • Medical Training & Education
  • By End-user
    • Hospitals & Clinics
    • Research Institutes & Laboratories
    • Pharmaceutical Companies
    • Academic Institutions
    • Others
  • By Region
    • North America
      • US
      • Canada
    • Latin America
      • Brazil
      • Mexico
      • Argentina
      • Colombia
      • Chile
      • Peru
      • Rest of Latin America
    • Europe
      • Germany
      • France
      • Italy
      • Spain
      • U.K.
      • BENELUX
      • CIS & Russia
      • Nordics
      • Austria
      • Poland
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • South Korea
      • India
      • Thailand
      • Indonesia
      • Malaysia
      • Vietnam
      • Australia & New Zealand
      • Rest of Asia Pacific
    • Middle East & Africa
      • Saudi Arabia
      • UAE
      • South Africa
      • Nigeria
      • Egypt
      • Israel
      • Turkey
      • Rest of MEA

Recent Developments

  • In May 2023, Bioprinting Solutions announced that it had partnered with the University of California, San Francisco to develop 3D-printed heart tissue. The partnership will use the university's expertise in heart disease to develop tissue that can be used to repair damaged hearts.
  • In April 2023, Organovo Holdings announced that it had received FDA approval to begin clinical trials of its 3D-printed bladder tissue. The trials will test the safety and effectiveness of the tissue in patients with bladder cancer.

Answers to Following Key Questions:

  • What will be the 3D-Printed Organs Market’s Trends & growth rate? What analysis has been done of the prices, sales, and volume of the top producers of Artificial Intelligence in the Agriculture Market?
  • What are the main forces behind worldwide 3D-Printed Organs Market? Which companies dominate 3D-Printed Organs Market?
  • Which companies dominate 3D-Printed Organs Market? Which business possibilities, dangers, and tactics did they embrace in the market?
  • What are the global Insight Engines industry's suppliers' opportunities and dangers in 3D-Printed Organs Market?
  • What is the Insight Engines industry's regional sales, income, and pricing analysis? In the 3D-Printed Organs Market, who are the distributors, traders, and resellers?
  • What are the main geographic areas for various trades that are anticipated to have astounding expansion over the 3D-Printed Organs Market?
  • What are the main geographical areas for various industries that are anticipated to observe astounding expansion for 3D-Printed Organs Market?
  • What are the dominant revenue-generating regions for 3D-Printed Organs Market, as well as regional growth trends?
  • By the end of the forecast period, what will the market size and growth rate be?
  • What are the main 3D-Printed Organs Market trends that are influencing the market's expansion?
  • Which key product categories dominate 3D-Printed Organs Market? What is 3D-Printed Organs Market’s main applications?
  • In the coming years, which 3D-Printed Organs Market technology will dominate the market?

TOC

  1. Executive Summary
  2. Introduction
    1. Key Takeaways
    2. Report Description
    3. Market Scope & Definition
    4. Stakeholders
  3. Research Methodology
      1. Market size
      2. Key data points from primary sources
      3. Key data points from secondary sources
      4. List of primary sources
      5. List of secondary sources
  4. Market Overview
    1. Introduction
    2. Industry Segmentation
    3. Market Trends Analysis
    4. Major Funding & Investments
    5. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunities
    6. Value Chain Analysis
  5. 3D-Printed Organs Market, By Organ Type
    1. Introduction
    2. Heart
    3. Liver
    4. Kidney
    5. Lung
    6. Skin
    7. Bone
    8. Pancreas
    9. Ear
    10. Eye
    11. Others
  6. 3D-Printed Organs Market, By Technology Type
    1. Extrusion-Based 3D Printing
    2. Laser-Assisted Printing
    3. Inkjet Printing
    4. Stereolithography
    5. Magnetic Levitation
    6. Laser Based
    7. Others
  7. 3D-Printed Organs Market, By Material Type 
    1. Biological Materials (Bioinks)
    2. Synthetic Polymers
    3. Hydrogels
    4. Ceramics
    5. Metals
    6. Biomaterials
  8. 3D-Printed Organs Market, By Application 
    1. Transplantation
    2. Research & Drug Testing
    3. Disease Modeling
    4. Regenerative Medicine
    5. Medical Training & Education
  9. 3D-Printed Organs Market, By End-user
    1. Hospitals & Clinics
    2. Research Institutes & Laboratories
    3. Pharmaceutical Companies
    4. Academic Institutions
    5. Others
  10. 3D-Printed Organs Market, By Geography
    1. North America
      1. U.S.
      2. Canada
    2. Latin America
      1. Brazil
      2. Mexico
      3. Argentina
      4. Rest of Latin America
    3. Europe
      1. UK
      2. Germany
      3. France
      4. Italy
      5. Spain
      6. Russia
      7. Rest of Europe
    4. Asia Pacific
      1. China
      2. Japan
      3. India
      4. South Korea
      5. Rest of Asia Pacific
    5. Rest of the world (RoW)
      1. Middle East
        1. UAE
        2. Saudi Arabia
        3. Israel
      2. Africa
        1. South Africa
        2. Rest of Africa
  11. Competitive Landscapes
    1. Introduction
    2. Top Companies Ranking
    3. Market Share Analysis
      1. Competition Dashboard
      2. Market Share Analysis (2022)
      3. Emerging company case studies
    4. Company Profiles
      1. Organovo Holdings Inc.
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      2. Modern Meadow
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      3. Poietis
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
        6. Rewards & Recognition
      4. REGEMAT 3D S.L.
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      5. Cellbricks
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      6. Nano3D Biosciences, Inc.
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      7. Medprin Regenerative Medical Technologies Co., Ltd
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      8. EnvisionTEC
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      9. nScrypt
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      10. Advanced Solutions, Inc.
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      11. Digilab Inc.
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      12. TeVido BioDevices
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      13. Aspect Biosystems Ltd.
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      14. Cyfuse Biomedical K.K.
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      15. CELLINK GLOBAL
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition

Table and Figures

 

Methodology:

At MarketDigits, we take immense pride in our 360° Research Methodology, which serves as the cornerstone of our research process. It represents a rigorous and comprehensive approach that goes beyond traditional methods to provide a holistic understanding of industry dynamics.

This methodology is built upon the integration of all seven research methodologies developed by MarketDigits, a renowned global research and consulting firm. By leveraging the collective strength of these methodologies, we are able to deliver a 360° view of the challenges, trends, and issues impacting your industry.

The first step of our 360° Research Methodology™ involves conducting extensive primary research, which involves gathering first-hand information through interviews, surveys, and interactions with industry experts, key stakeholders, and market participants. This approach enables us to gather valuable insights and perspectives directly from the source.

Secondary research is another crucial component of our methodology. It involves a deep dive into various data sources, including industry reports, market databases, scholarly articles, and regulatory documents. This helps us gather a wide range of information, validate findings, and provide a comprehensive understanding of the industry landscape.

Furthermore, our methodology incorporates technology-based research techniques, such as data mining, text analytics, and predictive modelling, to uncover hidden patterns, correlations, and trends within the data. This data-driven approach enhances the accuracy and reliability of our analysis, enabling us to make informed and actionable recommendations.

In addition, our analysts bring their industry expertise and domain knowledge to bear on the research process. Their deep understanding of market dynamics, emerging trends, and future prospects allows for insightful interpretation of the data and identification of strategic opportunities.

To ensure the highest level of quality and reliability, our research process undergoes rigorous validation and verification. This includes cross-referencing and triangulation of data from multiple sources, as well as peer reviews and expert consultations.

The result of our 360° Research Methodology is a comprehensive and robust research report that empowers you to make well-informed business decisions. It provides a panoramic view of the industry landscape, helping you navigate challenges, seize opportunities, and stay ahead of the competition.

In summary, our 360° Research Methodology is designed to provide you with a deep understanding of your industry by integrating various research techniques, industry expertise, and data-driven analysis. It ensures that every business decision you make is based on a well-triangulated and comprehensive research experience.

3D-Printed Organs Market
Customize your Report
• Tailored advice to Drive your Performance
• Product Planning Strategy
• New Product Stratergy
• Expanded Research Scope
• Comprehensive Research
• Strategic Consulting
• Provocative and pragmatic
• Accelerate Revenue & Growth
• Evaluate the competitive landscape
• Optimize your partner network
• Analyzing industries
• Mapping trends
• Strategizing growth
• Implementing plans
A comprehensive cogent custom study with Analyzing Industries, Mapping Trends, Straterging growth & Implementing Plans. An in-depth and breadth of composite research, which gives complete support of the generation and evaluation of growth opportunities, and best practices recognition to help increase the revenue. Request a Custom Research below.
Request Customization

Covered Key Topics

Growth Opportunities

Market Growth Drivers

Leading Market Players

Company Market Share

Market Size and Growth Rate

Market Trend and Technological

Research Assistance

We will be happy to help you find what you need. Please call us or write to us:

+1 510-730-3200 (USA Number)

Email: sales@marketdigits.com